Patients' Main Concerns About Having a Sibling Stem Cell Donor - A Grounded Theory Study

The Open Nursing Journal
Annika M Kisch, Anna Forsberg

Abstract

There is limited knowledge about the perspective of patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT) about having a sibling as donor. It is essential to understand the main concerns of stem cell recipients in order to enable nurses to provide person-centred care. The study aim was to explore patients' main concerns about having a sibling stem cell donor and how the patients handle them, from immediately before until one year after transplantation. Twenty-eight interviews were performed prospectively during one year with ten adult sibling stem cell recipients with a mean age of 52 years (range 19-68 years). The interviews were analyzed by the Grounded Theory method. The core category Recompensation summarises the process in the generated grounded theory including the three main categories; Invest, Compensate and Celebrate. Recompensation is defined as a lasting compensation given by the recipient to the sibling donor for the loss or harm suffered or effort made. The sense of having to reward, protect, appreciate, maintain peace and work on the relationship with the sibling donor at the same time as having to accept a serious illness, cope with their situation and promote their own recovery is strenu...Continue Reading

References

Jul 5, 2006·Bone Marrow Transplantation·S J LeeJ H Antin
Sep 6, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·John P MillerRoberta J King
Dec 9, 2008·Haematologica·Joerg HalterAlois Gratwohl
Jul 9, 2009·Bone Marrow Transplantation·P LjungmanUNKNOWN European Group for Blood and Marrow Transplantation
Feb 13, 2010·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Annemarie Coolbrandt, Mieke H F Grypdonck
Aug 7, 2010·International Journal of Qualitative Studies on Health and Well-being·Lillemor R-M Hallberg
Feb 22, 2012·Bone Marrow Transplantation·B PillayS Burney
Oct 22, 2013·JAMA : the Journal of the American Medical Association·UNKNOWN World Medical Association
Apr 12, 2014·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Annika KischMariette Bengtsson
Mar 31, 2015·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Annika KischMariette Bengtsson
Mar 26, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Linda J BurnsUNKNOWN Blood and Marrow Transplant Clinical Trials Network
Aug 26, 2017·The Open Nursing Journal·Annika M Kisch, Anna Forsberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.